Warning: The NCBI web site requires JavaScript to function. more...
HIV-1 associated dementia: symptoms and causes.
Ghafouri M, Amini S, Khalili K, Sawaya BE.
Retrovirology. 2006 May 19;3:28. Review.
Related citations
An update on the neuropathology of HIV in the HAART era.
Bell JE.
Histopathology. 2004 Dec;45(6):549-59. Review.
The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.
Welch K, Morse A; Adult Spectrum of Disease Project in New Orleans.
AIDS Patient Care STDS. 2002 Feb;16(2):75-81.
High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS.
Zhao L, Galligan DC, Lamers SL, Yu S, Shagrun L, Salemi M, McGrath MS.
Sci China C Life Sci. 2009 Jul;52(7):651-6. Epub 2009 Jul 30.
HIV-1-associated central nervous system dysfunction.
Krebs FC, Ross H, McAllister J, Wigdahl B.
Adv Pharmacol. 2000;49:315-85. Review.
The Neuropathology of HIV/AIDS.
Anthony IC, Bell JE.
Int Rev Psychiatry. 2008 Feb;20(1):15-24. Review.
Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.
Kramer-Hämmerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R.
Virus Res. 2005 Aug;111(2):194-213. Review.
Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
Lipton SA.
Brain Pathol. 1996 Oct;6(4):507-17. Review.
The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N.
J Neurovirol. 2002 Dec;8 Suppl 2:115-21. Review.
HIV-1-associated dementia during HAART therapy.
Aquaro S, Svicher V, Ronga L, Perno CF, Pollicita M.
Recent Pat CNS Drug Discov. 2008 Jan;3(1):23-33. Review.
Changing patterns in the neuropathogenesis of HIV during the HAART era.
Langford TD, Letendre SL, Larrea GJ, Masliah E.
Brain Pathol. 2003 Apr;13(2):195-210. Review.
Neurobiology of HIV.
Hult B, Chana G, Masliah E, Everall I.
Int Rev Psychiatry. 2008 Feb;20(1):3-13. Review.
Microglia in human immunodeficiency virus-associated neurodegeneration.
Garden GA.
Glia. 2002 Nov;40(2):240-51. Review.
Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy.
Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E; HNRC Group.
AIDS. 2002 May 3;16(7):1019-29.
Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.
Bell JE, Arango JC, Anthony IC.
J Neuroimmune Pharmacol. 2006 Jun;1(2):182-91. Epub 2006 May 5. Review.
[HIV glycoprotein 120: possible etiological agent of AIDS-associated dementia].
Galicia O, Sánchez-Alavez M, Méndez Díaz M, Navarro L, Prospero-García O.
Rev Invest Clin. 2002 Sep-Oct;54(5):437-52. Review. Spanish.
[Neurological complications of HIV infection].
Arendt G, Nolting T.
Nervenarzt. 2008 Dec;79(12):1449-62; 1463. German.
[HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
Kishida S.
No To Shinkei. 2004 Apr;56(4):301-10. Japanese. No abstract available.
The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj, Vanovac V, Veselinović M, Salemović D, Ranin J, Stefanova E.
Biomed Pharmacother. 2009 Sep;63(8):561-5. Epub 2008 Nov 5.
HIV-1 encephalopathy in children.
Gelbard HA, Epstein LG.
Curr Opin Pediatr. 1995 Dec;7(6):655-62. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on